CME Group director sells 500 shares at $280
Rhea-AI Filing Summary
CME GROUP INC. (CME) director Elizabeth A. Cook reported the sale of 500 shares of Class A common stock on September 14, 2026 at $280.11 per share through an entity described as a trust. Following this transaction, the trust holds 17,916 shares, and a separate joint account is reported holding 20 shares, both as indirect ownership. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 500 shares
Net Sell
2 txns
Insider
Cook Elizabeth A
Role
Director
Sold
500 shs ($140K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock Class A | 500 | $280.11 | $140K |
| holding | Common Stock Class A | -- | -- | -- |
Holdings After Transaction:
Common Stock Class A — 17,916 shares (Indirect, by Trust);
Common Stock Class A — 20 shares (Indirect, By Joint Account)
Key Figures
Shares sold: 500 shares
Sale price per share: $280.11 per share
Indirect holdings by trust after transaction: 17,916 shares
+2 more
5 metrics
Shares sold
500 shares
Class A common stock sold on September 14, 2026
Sale price per share
$280.11 per share
Reported price for the September 14, 2026 sale
Indirect holdings by trust after transaction
17,916 shares
Class A common stock held indirectly by trust after sale
Indirect holdings by joint account
20 shares
Class A common stock held indirectly through joint account
Net buy/sell shares in filing
-500 shares
Net result of reported non-derivative transactions
Key Terms
indirect, Common Stock Class A, Rule 10b5-1, Form 4
4 terms
indirect financial
"All reported CME shares are held <b>indirectly</b>."
Common Stock Class A financial
"sale of CME <b>Class A common stock</b> was executed"
Rule 10b5-1 regulatory
"No <b>Rule 10b5-1</b> trading plan is reported"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Form 4 regulatory
"after this <b>Form 4</b>?"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CME director Elizabeth A. Cook report?
Elizabeth A. Cook reported a sale of 500 shares of CME Class A common stock on September 14, 2026, executed through an indirectly owned trust at a reported price of $280.11 per share.
Was the CME (CME) insider sale by Elizabeth A. Cook made under a Rule 10b5-1 plan?
No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating the sale was made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.